Medicsight Share Discussion Threads

[chagzuki] 16/7/2007 19:24

First noteworthy share price rise last week since the initial peak. What was the reason?

[fryern] 09/7/2007 08:56

BEST BIT


The value of both of our subsidiaries, Medicsight and Medicexchange, continue to rise and I believe that these investments, along with our strong cash position, remain undervalued by the investment community. That is why I have invested a further $5 million in buying an additional one million shares.

[damanko] 09/7/2007 07:30

Yes, the link works fine, I'll put it in the header, thanks.

[fryern] 08/7/2007 21:20

Does the above link work for you?

My guess is the site is being updated.

[fryern] 08/7/2007 21:18

No nothing - unlikly too as my holding is not in my name yet - paperwork!

Good if Tim announces his CT parner

Luv it to be GE

[damanko] 07/7/2007 09:26

Interesting Fryern. I'm awaiting an email with news about Macniven & Cameron, have you heard anything? For me - after the success so far of Accsys & Medicsight, some positive news would complete the puzzle, started years ago with STG Holdings, when it started life as a property EIS. Long time ago.......

[fryern] 07/7/2007 06:26

July 06, 2007: 04:00 PM EST


LONDON, July 6 /PRNewswire-FirstCall/ -- MGT Capital Investments, Inc. , an investment company focused on the Healthcare Information Technology ("HCIT") sector, announced today that the Company's Chairman and CEO, Tim Paterson-Brown, has spent $5 million purchasing 1,000,000 shares of MGT stock from an existing shareholder in a private placement at $5.00 per share.

Separately, the Company announced that Mr. Paterson-Brown is scheduled to "ring the opening bell" at the American Stock Exchange ("AMEX") on Monday, July 9, 2007 at 9:30 a.m. Eastern time. Also on hand for the bell ringing will be MGT CFO Allan Rowley.

MGT Capital Investments joins the long list of AMEX-listed companies and dignitaries that have opened trading on the AMEX in a tradition that dates back to 1921.

Tim Paterson-Brown, Chairman and CEO, stated, "MGT has made significant progress in the year and half we have been trading on the AMEX, including the recent IPO of our subsidiary, Medicsight, which unlocked significant value for our shareholders. The value of both of our subsidiaries, Medicsight and Medicexchange, continue to rise and I believe that these investments, along with our strong cash position, remain undervalued by the investment community. That is why I have invested a further $5 million in buying an additional one million shares. We are poised to continue to execute on our growth plan, making strategic HCIT acquisitions that complement our expertise and experience, and continuing to develop our two subsidiaries. It is an honor to be part of this long-standing tradition and I am pleased for all the employees and shareholders of MGT to be able to ring the opening bell at the AMEX."

About MGT Capital Investments, Inc.

MGT Capital Investments is an investment company with two direct subsidiaries that focus solely on the dynamic and consolidating HCIT sector. The first subsidiary, Medicsight PLC, is a leading developer of computer-aided detection (CAD) and computer assisted reader (CAR) software solutions that are tested using one of the world's largest databases of verified CT scan data. Medicsight's CAD and CAR products help clinicians identify, measure, and analyze suspicious pathology, such as colorectal polyps and lung lesions. MGT Capital Investments has invested in and controls a second subsidiary, Medicexchange PLC, which operates Medicexchange.com, an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions for cardiac, thoracic, breast imaging, orthopedic, and gastro intestinal imaging. Medicexchange.com provides these solutions in a low-cost, on-demand and downloadable format, enhancing access to information and products for medical imaging professionals. Additional information can be found at

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.


Company contacts: For more information:
MGT Capital Investments, Inc. Investors:
Alex van Klaveren Stephanie Carrington / Zack Kubow
1410 Broadway [phone] / 7020
22nd Floor [e-mail]
New York, NY 10018 [e-mail]
[phone]
[e-mail]

[philjeans] 06/7/2007 15:15

damanko - just finished an interesting conversation with the co secy of M & C!

What's your e-mail - I'll copy you in privately - put it up on the web here and I'll note it - then you can delete.

[damanko] 05/7/2007 23:02

Hello philjeans. Welcome to the boat. I too am a holder of M&C, thanks to buying shares in STG some years ago. Explains, of course - my interest in Accsys & Medicsight. Are you registered on the finfoex forum? If so, you can email me from there. Or, if not - register.

Trouble with M&C is that last time I looked there were some 650 million shares in existence, so ....... 15% of one, 15% of the other, never amounted to a great deal. However, with AXS quadrupling, and Medicsight now coming onto investor's radar screens, we may have an out. But only if they float or offer "minority shareholders" a price to sell.

Did you get the letter from M&C 18 months or so ago advising that they were looking at buying us minnows out?

[philjeans] 05/7/2007 08:24

I have been watching this one (and accsys) as I hold shares in Macniven and Cameron - a private company now with substantial interests in both companies, and also in MGT - the US listed holding company.

Mac and Cam was previously STG Holdings - a small investment company traded on Ofex - which was subsequently de-listed and then went private.

My shares are therefore in limbo; Mac and Cam are very poor in keeping us minority holders up to date and I have no idea when, if ever, we can dispose of our shares. Or at what price!

But I think the fortunes will have improved greatly over the last 12 months!

Any one else aware of this, or in the same boat?

[fryern] 25/6/2007 11:54

To deliver the three year business plan they need to sign up 1,500 radiologist out of a global Radiologist population of 200,000.

They have already signed 5 partners Vital Images, TeraRexcon, Viatronics, 3 Mensio and Barco. They have Letters of Intent that will deliver all their 3 year business plan.

They will use partners and not deal direct in most cases with radiologist.

Expect a deal with a major scanner manufacturer.

[wjccghcc] 25/6/2007 10:21

Fair enough demanko. Thanks.

[fryern] 25/6/2007 09:03

WJCCGHCC

They have come to market at half the value of their 'peer' rivals.

So 220p is break even on that basis. They have a much better product and as damanko says top medical people behind them. You can check that out on the websites. This is UK/US/Japan/China/etc

[damanko] 25/6/2007 06:45

WJ - I understand what you're saying, and why. From most perspectives the market cap may seem excessive, however...... as Fryern says, the 3 year thing is way out. This software was developed in the 90's, originally it had a military application, before it was further researched/developed for the medical scanning industry. Two key events need to happen, then even the present market cap may seem conservative: The license deal spoken of, and regulatory approval in the States & Japan. Also, City insiders are backing not just the product, but the management. Over the past few years a series of appointments has been made (not all at board level) - bringing under MDST's roof some of the world's foremost scientific experts in this field.

[wjccghcc] 24/6/2007 22:52

Fryern, the only way is up - umm, that's eventually going to end in tears.

I can believe the margin is 90%. I hold IGP, one of the top two smart card management software companies in the world and their margins are 97% - their mkt cap is 14mm, not 200mm.

I also hold, AVV, again one of the top two global companies in design of power plants, oil & gas and shipbuilding. Last FY sales up 44% and profit of 28mm up 100%. Mkt cap? 600mm.

I'm convinced their software is world-beating and important from a screening perspective going forward - otherwise I wouldn't be wasting my time here.

However, 200mm is an awful lot for a company just breaking even, particularly if their market is growing at less than 10% pa according to their website.

"Radiologists expect the frequency of computed tomography procedures to grow by over 35% over the next five years (source: Frost & Sullivan research)."

[fryern] 24/6/2007 22:35

How about 5 million scans say @ $100 a scan

Margin 80%

That leaves $400m gross profit.............

Take out what you like for tax/overheads loads of carried forward losses so say £125m net

P/E of 30

Market cap. is £3750m

The limitation is the imagination.............

In the USA alone there were over 100m scans last year.....

[fryern] 24/6/2007 22:28

WJCCGHCC

The software took £50m to develop over the best part of a decade - I've been there. Three years is rubbish.

The margins are in excess of 80%. More likely 90%.

The company will be profitable in 2007. You are just not privy to what the institutions have bought into.

The only way is up.

This is population scanning of the upper classes to begin with. Upper classes because they care.



Thanks to my 'free' Medicsight scan I have been on heart pills now for over 5 years.

See it made headlines in The Sunday Times today.

Much better than a heart attack.

[wjccghcc] 24/6/2007 16:48

Yes, but Medicsight's mkt cap is an order of magnitude greater than Accsys.

Sales may not matter if it's a 20 mm mkt cap company, but 200mm?

According to the website, the software only took 3 years to develop which doesn't seem a lot compared to certain proprietary software products.

Now they're a plc, they really ought to put some financials on the website or at least the prospectus.

[damanko] 24/6/2007 09:47

Yes, there are interesting times ahead. I won't bother answering questions about sales, forecasts, P&L stuff, for now. The key now is news about license deals with the machine manufacturer(s). As you're well aware.

On the surface it is an almost uncanny mirror image of Accsys back in October 2005, just after they placed on AIM. Seems that MGT's longer term share price expectation for Mediscight may well prove to be shorter term, if it follows the same pattern as AXS.

[fryern] 24/6/2007 08:14

From the MGT website...........

So it's $40m cash in hand not $25m - even better

At the same time as the IPO, MGT has reduced its holding in Medicsight to 85 million shares representing 54.7% of the issued share capital, and has raised approximately $24.5 million net of expenses. This leaves MGT with over $40 million in cash in addition to its shareholdings in Medicsight and Medicexchange.

[fryern] 24/6/2007 08:05

Hi Damanka,

Adjusted for 54.7% ie 85m sahres. Not sure where the 5m went I think cashed in. So cash balance should be more than $25m

Sharecast:-

Medicsight got off to a strong start Thursday and extended gains at the end of the week, soaring to 132p from a placing price of 110p, valuing the firm at over £200m.

MGT has 40m shares

Holds:-

85m Medicsight plc shares = $233.75m (85 x £1.375 x 2 dollars to a £1)
45m Medicsight Exchange shares = $99m
Cash $25m

Add it up and divide by 40m

=$8.94

(Note Medicsight Exchange share value comes from a circular).


Target price for MDST is £4 short term................

So

MGT

85m Medicsight plc shares = $680m (85 x £4.00 x 2 dollars to a £1)
45m Medicsight Exchange shares = $99m
Cash $25m

= $20.1

[wjccghcc] 23/6/2007 15:50

But do they have any sales?